Scientific posters

AACR Annual Meeting 2021

Combination of ATACs with Immune checkpoint inhibitors shows synergistic therapeutic effect

AACR Annual Meeting 2021

Preclinical evaluation of anti-CD37 Antibody-Targeted Amanitin Conjugates (ATAC) in B-cell malignancies

AACR Annual Meeting 2021

Amanitin-based ADCs targeting PSMA as novel therapeutic modality for prostate cancer therapy

World ADC Congress 2019

Preclinical evaluation of anti-HER2 ATACs on HER2low breast cancer with chromosome 17p deletion

AACR Annual Meeting 2019

Preclinical evaluation of anti-HER2 ATACs on HER2low breast cancer with chromosome 17p deletion

AACR 2018

SAR relationship of amanitin and optimization of linker-amanitin deriv. for solid tumors

AACR 2018

Preclinical evaluation of an anti-PSMA Antibody Targeted Amanitin Conjugate (ATAC)

ASH Annual Meeting 2017

Preclinical Evaluation of HDP-101, a Novel anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma

PEGS 2017

CD19 – a potential target for
Amanitin Based ADCs

AACR Annual Meeting 2017

Preclinical evaluation of HDP-101 an anti-BCMA antibody-drug conjugate

AACR Annual Meeting 2017

CD19 – a potential target for
Amanitin-based ADCs

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.